IP Library › Patent Application 63012781
Patent Application Provisional
App. No. 63/012,781 · Confirmation No. 3114

Activating Endogenous Antimicrobials To Treat SARS-COV-2 Infection

Applicant: EIRGEN PHARMA LTD.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2021-04-01 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2021-04-01 APP.FILE.REC Filing Receipt 3 View
2021-03-30 R48.REQ Request under Rule 48 correcting inventorship 2 View
2021-03-30 R3.73 Assignee showing of ownership per 37 CFR 3.73 2 View
2021-03-30 R46C.REQ Request under 37CFR1.46(c) to correct, update, change applicant 1 View
2021-03-30 R3.73 Assignee showing of ownership per 37 CFR 3.73 15 View
2021-03-30 WFEE Fee Worksheet (SB06) 2 View
2021-03-30 N417 Electronic Filing System Acknowledgment Receipt 3 View
2021-03-30 ADS Application Data Sheet 5 View
2020-05-13 APP.FILE.REC Filing Receipt 3 View
2020-05-04 ADS Application Data Sheet 4 View
2020-05-04 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-04-20 ADS Application Data Sheet 4 View
2020-04-20 TR.PROV Provisional Cover Sheet (SB16) 2 View
2020-04-20 DRW Drawings-only black and white line drawings 15 View
2020-04-20 WFEE Fee Worksheet (SB06) 2 View
2020-04-20 N417 Electronic Filing System Acknowledgment Receipt 3 View
2020-04-20 SPEC Specification 41 View
2020-04-20 CLM Claims 12 View
2020-04-20 ABST Abstract 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/012,781
Filed
2020-04-20